WEDNESDAY, March 3, 2021 (HealthDay News) — Two new studies suggest that the jury is still out on whether the arthritis drug tocilizumab helps those with severe COVID-19. Both reports were published recently in the New England Journal of Medicine. The first, from scientists at the University of California, SanContinue Reading

TUESDAY, March 2, 2021 (HealthDay News) — Strep throat doesn’t appear to aggravate Tourette syndrome and other chronic tic disorders in youngsters, according to a new study. But it did find an association between strep infection and increased hyperactivity and impulsiveness among kids with ADHD. People with chronic tic disordersContinue Reading

MONDAY, March 1, 2021 (HealthDay News) — Older Americans on a Medicare Advantage plan could face hospital bills of $1,000 or more if private insurers start charging out-of-pocket costs for lifesaving COVID-19 care, a new study warns. Cost data show that Medicare Advantage patients pay an average $987 out-of-pocket whenContinue Reading

THURSDAY, Feb. 25, 2021 (HealthDay News) — If you think you can safely exercise without your mask in a gym during the pandemic, two new government reports show you are mistaken. Coronavirus outbreaks at fitness centers in Chicago and Honolulu last summer were likely the result of exercisers and instructorsContinue Reading

THURSDAY, Feb. 25, 2021 (HealthDay News) — Dental hygienists have a low rate of COVID-19, even though their jobs are considered high-risk, a new study says. The U.S. Occupational Safety and Health Administration (OSHA) declared hygienists at high risk for COVID-19, so researchers decided to investigate. They analyzed survey dataContinue Reading

WEDNESDAY, Feb. 24, 2021 (HealthDay News) — Hungry for good news on the pandemic? One epidemiologist believes Americans might reach herd immunity to the new coronavirus as soon as late spring. That’s the view held by Suzanne Judd, a professor with the school of public health at the University ofContinue Reading

WEDNESDAY, Feb. 24, 2021 (HealthDay News) — Protective immune system antibodies that develop after being infected with COVID-19 last for at least a few months, a new study suggests. And reinfection does seem to be relatively rare. That could have big implications for public health and societies, including allowing peopleContinue Reading

WEDNESDAY, Feb. 24, 2021 (HealthDay News) — During the pandemic, people with asthma have worried that their respiratory condition might raise their risk of severe illness or death from COVID-19, but new research findings should calm their fears. After analyzing data from 57 studies that included a total of overContinue Reading